Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

UK regulator reports 30 clot cases linked to AstraZeneca jab

Britain’s medicines regulator says it has identified 30 cases of rare blood clot events associated with the AstraZeneca coronavirus vaccine but stressed the benefits “continue to outweigh any risks.”

Via AP news wire
Saturday 03 April 2021 10:54 BST
Virus Oubreak AstraZeneca Explainer
Virus Oubreak AstraZeneca Explainer (AP)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Britain’s medicines regulator said it has identified 30 cases of rare blood clot events associated with the AstraZeneca coronavirus vaccine but stressed the benefits “continue to outweigh any risks.”

The Medicines and Healthcare Regulatory Agency said the risk associated with this type of blood clot is “very small” and that the public should continue to take up the vaccine when offered it.

The agency said late Friday the cases relate to the period up to March 24, during which 18.1 million doses of the vaccine had been administered and that it hadn't received any similar reports with regard to the Pfizer-BioNTech vaccine.

Concerns over the AstraZeneca vaccine prompted some countries including Canada, France Germany and the Netherlands to restrict its use to older people.

The World Health Organization has urged countries to continue using the jab.

___

Follow AP’s pandemic coverage at:

https://apnews.com/hub/coronavirus-pandemic

https://apnews.com/hub/coronavirus-vaccine

https://apnews.com/UnderstandingtheOutbreak

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in